Type III hyperlipoproteinemia unmasked by HIV anti-retroviral therapy Frederick F. Samaha, MD, Bonnie Ky, MD, Vincent Lo Re, MD The American Journal of Medicine Volume 118, Issue 6, Pages 691-692 (June 2005) DOI: 10.1016/j.amjmed.2005.03.024 Copyright © 2005 Elsevier Inc. Terms and Conditions
Figure Total cholesterol and triglyceride levels at baseline, after initiation of HIV medications (arrow 1), and after the initiation of atorvastatin (arrow 2). The American Journal of Medicine 2005 118, 691-692DOI: (10.1016/j.amjmed.2005.03.024) Copyright © 2005 Elsevier Inc. Terms and Conditions